Literature DB >> 15908687

Chemotherapy sensitivity and response assays: are the ASCO guidelines for clinical trial design too restrictive?

H Samuel Wieand.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15908687     DOI： 10.1200/JCO.2005.05.321

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Evaluation of chemoresponse assays as predictive markers.

Authors:  E L Korn; B Freidlin
Journal:  Br J Cancer       Date:  2015-01-13       Impact factor: 7.640

2.  Stratified phase II trial to establish the usefulness of the collagen gel droplet embedded culture-drug sensitivity test (CD-DST) for advanced gastric cancer.

Authors:  Hiroyuki Naitoh; Hiroshi Yamamoto; Satoshi Murata; Hisayuki Kobayashi; Katsunori Inoue; Tohru Tani
Journal:  Gastric Cancer       Date:  2013-12-08       Impact factor: 7.370

3.  Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer.

Authors:  C W Michalski; M Erkan; D Sauliunaite; T Giese; R Stratmann; C Sartori; N A Giese; H Friess; J Kleeff
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

4.  Evaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective study.

Authors:  C Tian; D J Sargent; T C Krivak; M A Powell; M J Gabrin; S L Brower; R L Coleman
Journal:  Br J Cancer       Date:  2014-07-08       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.